Sigma Planning Corp Decreases Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Sigma Planning Corp cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 46.4% in the 4th quarter, HoldingsChannel reports. The firm owned 3,128 shares of the financial services provider’s stock after selling 2,707 shares during the quarter. Sigma Planning Corp’s holdings in iShares Biotechnology ETF were worth $425,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Glass Jacobson Investment Advisors llc increased its position in shares of iShares Biotechnology ETF by 150.6% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 122 shares during the last quarter. Values First Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $43,000. Tennessee Valley Asset Management Partners bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $44,000. Horizon Bancorp Inc. IN bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $44,000. Finally, Massmutual Trust Co. FSB ADV grew its stake in shares of iShares Biotechnology ETF by 164.2% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock worth $49,000 after acquiring an additional 225 shares during the period. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.7 %

IBB stock opened at $126.49 on Friday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16. The stock has a fifty day moving average of $134.45 and a 200-day moving average of $129.71.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were paid a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.40%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.